Catalyst Wire Dossier Catalyst Wire Dossier

PIASKY

crovalimab · Genentech, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for PIASKY, covering 2024-06-20 to 2026-02-10. Get the full timeline:

Most recent: EMA Authorised: Piasky (Crovalimab) — Roche Registration GmbH

See pricing